Ondansetron Hydrochloride Tablets

Similar documents
Egualen Sodium Granules

LUMEFANTRINUM LUMEFANTRINE

CYCLOSERINE Final text for addition to The International Pharmacopoeia. (November 2008) CYCLOSERINUM CYCLOSERINE

ARTEMETHER AND LUMEFANTRINE ORAL SUSPENSION:Final text for addition to The International Pharmacopoeia (November 2008)

ARTEMETHER AND LUMEFANTRINE TABLETS: Final text for addition to The International Pharmacopoeia (July 2008)

NEVIRAPINE ORAL SUSPENSION Final text for addition to The International Pharmacopoeia (February 2009)

EFAVIRENZ Final text for addition to The International Pharmacopoeia

DOXYCYCLINE HYCLATE Final text to replace published monograph in The International Pharmacopoeia (November 2007)

BRIEFING. (EXC: K. Moore.) RTS C Propylparaben C 10 H 12 O Benzoic acid, 4 hydroxy, propyl ester; Propyl p hydroxybenzoate [ ].

USP 36 Official Monographs / Metformin carding the first 3 ml of filtrate. Transfer 25 ml of the Analysis

BRIEFING. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition Loss on drying Readily carbonizable substances

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

Should you have any questions, please contact Mary P. Koleck, Ph.D., Scientific Liaison ( or

IDENTIFICATION AND DETERMINATION OF HYDROQUINONE IN COSMETIC PRODUCTS 2 14/11/17 ACM 003 BY TLC AND HPLC

Dissolution Test 5 was validated using a Zodiac C18 brand of L1 column. The typical retention time for atorvastatin is about min.

The Isosorbide Mononitrate Extended-Release Tablets Revision Bulletin supersedes the currently official monograph.

ADVANTAME (TENTATIVE)

Revision Bulletin 27 Jan Feb 2017 Non-Botanical Dietary Supplements Compliance

MEDROXYPROGESTERONE INJECTION

ANALYTICAL METHOD PROCEDURES

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Revision Bulletin 29 Dec Jan 2018 Non-Botanical Dietary Supplements Compliance

Amendment to the Enforcement Ordinance of the Food Sanitation Law and the Standards and Specifications for Foods and Food Additives.

This method describes the identification of the following prohibited colorants in cosmetic products:

SPECIFICATION & TEST PROCEDURE SODIUM SALICYLATE Technical. Molecular weight : Reference : In-house

Chem 321 Name Answer Key D. Miller

ASPARTAME. Not less than 98% and not more than 102% on the dried basis. White, odourless, crystalline powder, having a strong sweet taste

Chapter 5: Identification, Assay and Related Substances

ADVANTAME. Not less than 97.0% and not more than 102.0% on the anhydrous basis. Sweetener, flavour enhancer

GUACO FOR HOMOEOPATHIC PREPARATIONS GUACO FOR HOMOEOPATHIC PREPARATIONS

FLUDEOXYGLUCOSE ( 18 F) INJECTION: Final text for addition to The International Pharmacopoeia (January 2009)

12 Nicarbazin Nicarbazin (4,4 -dinitro carbanilid (DNC) and 2-hydroxy-4,6-dimethyl pyrimidine (HDP))

Revision Bulletin Official April 1, 2014 Alprazolam 1

A. GENERAL NOTICES. Ninth Edition, which may be abbreviated as JSFA-IX.

TEMPLATE FOR AN EXAMPLE STANDARD TEST METHOD

Additionally, minor editorial changes have been made to update the monograph to current USP style.

CHAPTER - 3 ANALYTICAL PROFILE. 3.1 Estimation of Drug in Pharmaceutical Formulation Estimation of Drugs

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB5009.

TERTIARY BUTYLHYDROQUINONE

Chapter 4: Verification of compendial methods

637. Thiamethoxam. HPLC method

IDENTIFICATION OF STEROIDS IN COSMETIC PRODUCTS BY TLC AND HPLC 1 02/12/2005 ACM 007 A. THIN LAYER CHROMATOGRAPHY (TLC)

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

16 Malachite green 17 Leucomalachite green

TECHNICAL TEMEPHOS. 1. Specification. Full specification WHO/SIT/19.R4 Revised 10 December Description

POLYVINYL ALCOHOL. SYNONYMS Vinyl alcohol polymer, PVOH, INS No DEFINITION DESCRIPTION FUNCTIONAL USES CHARACTERISTICS

Supporting Information

Dissolution Test 2 was validated using an Inertsil ODS-3V brand of L1 column. The typical retention time for donepezil is about 5.5 min.

H - Helium R... Hypoxanthine R

*Correspondence to:

PYRIPROXYFEN TECHNICAL

Lonicera japonica Flower Dry Extract. Proposed For Development Version 0.1. Published on Herbal Medicines Compendium (

Dehydrated Alcohol. » Dehydrated Alcohol contains not less than 99.2 percent, Pharmacopeial Forum Vol. 30(5) [Sept. Oct. 2004] HARMONIZATION 1847

Introduction to Pharmaceutical Chemical Analysis

INDIGOTINE. Disodium 3,3'-dioxo-[delta 2,2' -biindoline]-5,5'-disulfonate (principal component) (principal component)

Supporting Information

University of Wisconsin Chemistry 116 Preparation and Characterization of Aspirin and Some Flavoring Esters *

Lonicera japonica Flower Powder. Proposed For Development Version 0.1. Published on Herbal Medicines Compendium (

USP 35 Official Monographs / Oxaliplatin 4143 DEFINITION

Supporting Information

Fumonisin. Fumonisin B 1 Fumonisin B 2. Fumonisin B 3. CAS No.:

Figure S1 - Enzymatic titration of HNE and GS-HNE.

CIPAC. CIPAC Free relevant impurities methods:

Chemistry 3200 High Performance Liquid Chromatography: Quantitative Determination of Headache Tablets

PHYSICAL CONSTANTS: MELTING POINTS, BOILING POINTS, DENSITY

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

School of Chemistry UNIVERSITY OF KWAZULU-NATAL, WESTVILLE CAMPUS JUNE 2009 EXAMINATION CHEM340: INSTRUMENTAL ANALYSIS.

What actually are dietary supplements? They are consumed in large quantities, but they

Electronic Supplementary Information for. A Redox-Nucleophilic Dual-Reactable Probe for Highly Selective

CHAPTER V ANALYTICAL METHODS ESTIMATION OF DICLOFENAC. Diclofenac (gift sample from M/s Micro Labs Ltd., Pondicherry)

Synthesis of Dihydroquinoline Based Merocyanines as Naked Eye and Fluorogenic sensors for Hydrazine Hydrate in Aqueous Medium

SUPPLEMENTARY INFORMATION

TLC Densitometric Quantification of Vasicine, Vasicinone and Embelin from Adhatoda zeylanica leaves and Embelia ribes fruits

Annex 2 Formaldehyde

CHEMICAL SEPARATION EXPERIMENT 2

Teacher Resource and Assessment Book Exercises Unit 3 answers


Stability indicating RP-HPLC method for determination of azilsartan medoxomil in bulk and its dosage form

Draft Method proposal: determination of glucoheptonic acid (HGA) in fertilizers.

VALIDATION OF A UPLC METHOD FOR A BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE TOPICAL SOLUTION

Int. J. Pharm. Sci. Rev. Res., 30(2), January February 2015; Article No. 09, Pages: 63-68

IDENTIFICATION TESTS FOR DURACOR TABLETS

BRIEFING. (EM2: K. Moore.) RTS C Add the following: Methylcellulose

STABILITY INDICATING METHOD OF RELATED IMPURITIES IN VENLAFAXINE HYDROCHLORIDE SUSTAINED RELEASE TABLETS

H 3 CO H 3 CO S CH 3

Diquat 1,1 -ethylene-2,2 -bipyridium dibromide salt Paraquat 1,1 -dimethyl-4,4 -bipyridium dichloride salt Initial Preparation

SUPPLEMENTARY INFORMATION

TECHNICAL BRODIFACOUM

5 Efrotomycin. [Summary of efrotomycin] ET A 2 ET A 1 ET B 2 ET B 1 C 59 H 88 N 2 O 20 MW: 1145

Supplementary Note 1 : Chemical synthesis of (E/Z)-4,8-dimethylnona-2,7-dien-4-ol (4)

All solvents and reagents were used as obtained. 1H NMR spectra were recorded with a Varian

BENZYLPIPERAZINE Latest Revision: June 1, 2005

Method Development and Validation Of Prasugrel Tablets By RP- HPLC

Chromatography Extraction and purification of Chlorophyll CHM 220

CfE Higher Chemistry. Unit 3: Chemistry in Society. Chemical Analysis as part of quality control

Selective Formation of Benzo[c]cinnoline by Photocatalytic Reduction of 2,2 Dinitrobiphenyl with TiO 2 and UV light irradiation

Effect of Conjugation and Aromaticity of 3,6 Di-substituted Carbazole On Triplet Energy

OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT

Transcription:

Ondansetron Hydrochloride Tablets Dissolution <6.10> Perform the test with 1 tablet of Ondansetron Hydrochloride Tablets at 50 revolutions per minute according to the Paddle method, using 900 ml of water as the dissolution medium. Start the test, withdraw not less than 20 ml of the medium at the specified minute after starting the test, and filter through a membrane filter with a pore size not exceeding 0.45 µm. Discard the first 10 ml of the filtrate, pipet V ml of the subsequent filtrate, add water to make exactly V ml so that each ml contains about 2.5 µg of ondansetron hydrochloride (C 18 H 19 N 3 O HCl) according to the labeled amount, and use this solution as the sample solution. Separately, weigh accurately about 28 mg of Ondasetron Hydrochloride RS (separately, determine the water <2.48> with 50 g by direct titration in volumetric titration), and dissolve in the water to make exactly 200 ml. Pipet 4 ml of this solution, add water to make exactly 200 ml, and use this solution as the standard solution. Perform the test with exactly 100 µl each of the sample solution and standard solution as directed under Liquid Chromatography <2.01> according to the following conditions, and determine the peak areas, A T and A S, of ondansetron of both solutions. The requirements are met if Ondansetron Hydrochloride Tablets conform to the dissolution requirements. Dissolution rate (%) with respect to the labeled amount of ondansetron (C 18 H 19 N 3 O) = M S A T /A S V'/V 1/C 9 0.890 M S : Amount (mg) of Ondansetron Hydrochloride RS, calculated on the anhydrous basis C: Labeled amount (mg) of ondansetron (C 18 H 19 N 3 O) in 1 tablet Operating conditions Detector: An ultraviolet absorption photometer (wavelength: 216 nm). Column: A stainless steel column 4.6 mm in inside diameter and 15 cm in length, packed with octadecylsilanized silica gel for liquid chromatography (5 µm in particle diameter). Column temperature: A constant temperature of about 25ºC. Mobile phase: Dissolve 1.56 g of sodium dihydrogen phosphate dihydrate in 500 ml of water, and adjust the ph to 5.4 with sodium hydroxide TS. To 500 ml of this solution add 500 ml of acetonitrile. Flow rate: Adjust the flow rate so that the retention time of ondansetron is about 6 minutes. System suitability System performance: When the procedure is run with 100 μl of the standard solution under the above operating conditions, the number of theoretical plates and the symmetry factor of the peak of - 1 -

ondansetron are not less than 2000 and not more than 2.0, respectively. System repeatability: When the test is repeated 6 times with 100 µl of the standard solution under the above operating conditions, the relative standard deviation of the peak area of ondansetron is not more than 1.5%. Dissolution Requirements Labeled amount* Specified minute Dissolution rate 2 mg 15 minutes Not less than 80% 4 mg 15 minutes Not less than 80% *as Ondansetron Ondansetron Hydrochloride RS C 18 H 19 N 3 O HCl 2H 2 O: 365.85 (±)-2,3-dihydro-9-methyl-3- [(2-methylimidazol-1-yl)methyl]carbazol-4-(1H)-one monohydrochloride dihydrate. It meets the following reuirements. Purify according to the following method if needed. Purification method Recrystalize ondansetron hydrochloride hydrate in a mixture of 2-propanol and water (2:1), previously dried under reduced pressure at 50ºC for 3 hours, and allow to stand in an incubator at 25ºC and 75% relative humidity for more than 12 hours. Description Ondansetron Hydrochloride RS occurs as a white to pale yellowish white crystalline powder. A solution of Ondansetron Hydrochloride RS (1 in 50) shows no optical rotation. Identification (1) Determine the infrared absorption spectrum of Ondansetron Hydrochloride RS as directed in the paste method under Infrared Spectrophotometry <2.25>: it exhibits absorption at the wave numbers of about 3180 cm -1, 1640 cm -1, 1282 cm -1, 761 cm -1, and 751 cm -1. (2) Determine the 1 H spectrum of a solution of Ondansetron Hydrochloride RS in deuterated dimethylsulfoxide for nuclear magnetic resonance spectroscopy (1 in 100), using tetramethylsilane for nuclear magnetic resonance spectroscopy as an internal reference compound, as directed under Nuclear Magnetic Resonance Spectroscopy <2.21>: it exhibits single signals A and B, at around δ 2.7 ppm and at around δ 3.7 ppm, and AMX-type quartet signals C and D, at around δ 4.3 ppm and at around δ4.7 ppm. The ratio of the integrated intensity of each signal, A:B:C:D, is about 3:3:1:1. Purity (1) Related substances (i) Dissolve 20 mg of Ondansetron Hydrochloride RS in 200 ml of the mobile phase, and use this solution as the sample solution. Pipet 1 ml of the sample solution, and add the mobile phase to make exactly 50 ml. Pipet 5 ml of this solution, add the mobile phase to make exactly 20 ml, and use this solution as the standard solution. Perform the test with exactly 10 µl each of the sample solution and standard solution as directed under Liquid Chromatography <2.01> according to the following conditions. Determine each peak area of both solutions by the automatic integration - 2 -

method: the total area of the peaks other than ondansetron obtained from the sample solution is not larger than the peak area of ondansetron from the standard solution. For this calculation, use the areas of the peaks, having the relative retention time of about 0.29 with respect to ondansetron, after multiplying by the sensitivity factor, 0.77. Operating conditions Detector: An ultraviolet absorption photometer (wavelength: 216 nm). Column: A stainless steel column 4.6 mm in inside diameter and 20 cm in length, packed with cyanopropylsilanized silica gel for liquid chromatography (5 µm in particle diameter). Column temperature: A constant temperature of about 25ºC. Mobile phase: Dissolve 1.56 g of sodium dihydrogen phosphate dihydrate in 500 ml of water, and adjust the ph to 5.4 with sodium hydroxide TS. To 500 ml of this solution add 500 ml of acetonitrile. Flow rate: Adjust the flow rate so that the retention time of ondansetron is about 6 minutes. Time span of measurement: About 2 times as long as the retention time of ondansetron beginning after the solvent peak. System suitability Test for required detectability: Pipet 2 ml of the standard solution, and add the mobile phase to make exactly 10 ml. Confirm that the peak area of ondansetron obtained from 10 µl of this solution is equivalent to 14 to 26% of that from 10 µl of the standard solution. System performance: When the procedure is run with 10 μl of the standard solution under the above operating conditions, the number of theoretical plates and the symmetry factor of the peak of ondansetron are not less than 2000 and not more than 2.0, respectively. System repeatability: When the test is repeated 6 times with 10 µl of the standard solution under the above operating conditions, the relative standard deviation of the peak area of ondansetron is not more than 5.0%. (ii) Dissolve 12.5 mg of Ondansetron Hydrochloride RS in 1 ml of methanol, and use this solution as the sample solution. Pipet 0.5 ml of this solution, and add methanol to make exactly 25 ml. Pipet 1 ml of this solution, add methanol to make exactly 10 ml, and use this solution as the standard solution. Perform the test with these solutions as directed under Thin-layer Chromatography <2.03>. Spot 20 µl each of the sample solution and standard solution on a plate of silica gel with fluorescent indicator for thin-layer chromatography. Develop the plate with a mixture of chloroform, ethyl acetate, methanol and ammonia solution (28)(90:50:40:1) to a distance of about 15 cm, and air-dry the plate. Examine under ultraviolet light (main wavelength: 254 nm): the spots obtained with other than the principal spot is not more intense than that with the standard solution. (2) 2-propanol Weigh accurately about 0.1 g of Ondansetron Hydrochloride RS, transfer to a 3 ml glass bottle, add exactly 2 ml of the internal standard solution, and stopper tightly. Warm the - 3 -

glass bottle in a water bath at 50ºC for 10 to 15 minutes, dissolve with shaking, cool to room temperature, and use this solution as the sample solution. Separately, weigh accurately 40 µl of 2- propanol, add the internal standard solution to make exactly 40 ml, and use this solution as the standard solution. Perform the test with 1 µl each of the sample solution and standard solution as directed under Gas Chromatography <2.02> according to the following conditions, and calculate the ratios, Q T and Q S, of the peak area of 2-propanol to that of the internal standard of each solution: the amount of 2-propanol is not more than 0.2%. Amount (%) of 2-propanol = Q T /Q S 1/W 1/5 0.79 M: Amount (g) of sample 0.79: Density (g/ml) of 2-propanol Internal standard solution Diluted ethanol (99.5) (1 in 500). Operating conditions Detector: A hydrogen flame-ionization detector. Column: A glass column 3 mm in inside diameter and 2 m in length, packed with porous ethylvinylbenzene-divinylbenzene copolymer for gas chromatography (150 to 180 µm in particle diameter) (0.0075 µm in average pore size, 500 600m 2 /g). Column temperature: A constant temperature of about 170ºC. Carrier gas: Nitrogen. Flow rate: Adjust the flow rate so that the retention time of the internal standard is about 3 minutes. System suitability System performance: When the procedure is run with 1 µl of the standard solution under the above operating conditions, the internal standard and 2-propanol are eluted in this order with the resolution between these peaks being not less than 1.5. System repeatability: When the test is repeated 6 times with 1 µl of the standard solution under the above operating conditions, the relative standard deviation of the ratio of the peak area of 2- propanol to that of the internal standard is not more than 1.5%. Water <2.48>: 9.6 10.2% (50 mg, volumetric titration, direct titration). Content: not less than 99.5%, calculated on the anhydrous basis. Assay Weigh accurately about 50 mg of Ondansetron Hydrochloride RS, dissolve in 50 ml of a mixture of acetic anhydride and acetic acid for nonaqueous titration (7:3), and titrate <2.50> with 0.1 mol/l perchloric acid VS - 4 -

(potentiometric titration). Perform a blank determination in the same manner, and make any necessary correction. Each ml of 0.01 mol/l perchloric acid VS = 3.298 mg of C 18 H 19 N 3 O HCl - 5 -